Enfusion is a company that simplifies investment management operations by integrating front, middle, and back-office functions into a single cloud-native SaaS platform. Their mission is to provide a unified solution that enhances operational efficiency and data accuracy through a shared golden data set. Key services offered by Enfusion include investment management software, portfolio management, risk management, and reporting solutions tailored for asset managers and financial institutions.
Manage global portfolios with real-time visibility across asset classes; Scale multi-asset and alternative strategies; Unify front, middle, and back office operations with a single security master; Monitor real-time risk exposure across geographies; Automate compliance with end-to-end pre- and post-trade oversight; Process $10T in assets across public and private markets; Simplify NAIC and Solvency II reporting
The main competitors of Enfusion in the fintech space include:
Enfusion offers a range of key products and services designed to simplify investment management operations, including:
Recent news related to Enfusion includes the announcement of a merger with Clearwater Analytics. Enfusion shareholders must choose their payment type by April 16, 2025, as part of this acquisition process. The merger, valued at $1.5 billion, aims to enhance Clearwater's investment management platform by integrating Enfusion's SaaS solutions. Additionally, there are ongoing investigations regarding the adequacy of the sale price and process by legal firms.
Serves 2,400 global clients; Manages $10T in assets; Recognized as Best EMS/OMS Provider in Fund Intelligence Operations and Services Awards; Named Best Institutional Investment Solution at FinTech Breakthrough Awards; Trusted by leading firms including Blackstone, Qualcomm, and China Taiping; Single-instance, multi-tenant architecture with real-time updates and no downtime